carbidopa, levodopa drug combination and Liver Neoplasms

carbidopa, levodopa drug combination has been researched along with Liver Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cowie, F; Grosset, DG; Watson-Fargie, T; White, J	1

Other Studies

1 other study(ies) available for carbidopa, levodopa drug combination and Liver Neoplasms

Article	Year
Possible modulation of concurrent Parkinson's disease in the management of metastatic GIST: a review of two cases. The journal of the Royal College of Physicians of Edinburgh, 2018, Volume: 48, Issue:3 Topics: Aged; Antineoplastic Agents; Antiparkinson Agents; Carbidopa; Drug Combinations; Gastrectomy; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Levodopa; Liver Neoplasms; Male; Parkinson Disease; Severity of Illness Index; Stomach Neoplasms	2018

Article

Year

Possible modulation of concurrent Parkinson's disease in the management of metastatic GIST: a review of two cases.

The journal of the Royal College of Physicians of Edinburgh, 2018, Volume: 48, Issue:3

Topics: Aged; Antineoplastic Agents; Antiparkinson Agents; Carbidopa; Drug Combinations; Gastrectomy; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Levodopa; Liver Neoplasms; Male; Parkinson Disease; Severity of Illness Index; Stomach Neoplasms

2018